EVOLUTION OF THE UTILIZATION OF THE AIFA 5% FUND FOR ORPHAN DRUGS AND RARE DISEASES

被引：0
|
作者：
Tartarelli, F. [1 ]
Viola, V. [2 ]
Lidonnici, D. [3 ]
Marcellusi, A. [4 ]
机构：
[1] Sapienza Univ Roma, Rome, Italy
[2] Pharmavalue, Rome, Italy
[3] More Access Srl SB, Legnano, MI, Italy
[4] Univ Roma Tor Vergata, Fac Econ, Dept Econ & Finance, Econ Evaluat & HTA EEHTA CEIS, Rome, Italy
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR29
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [1] Rare diseases and orphan drugs
    Aronson, JK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) : 243 - 245
  • [2] Rare diseases and orphan drugs
    Irena Melnikova
    Nature Reviews Drug Discovery, 2012, 11 : 267 - 268
  • [3] Rare diseases and orphan drugs
    Melnikova, Irena
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (04) : 267 - 268
  • [4] RARE DISEASES AND ORPHAN DRUGS
    DAINA, E
    LANCET, 1994, 343 (8912): : 1560 - 1561
  • [5] Orphan drugs and rare diseases
    Schulze-Bonhage, Andreas
    Stephani, Ulrich
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (04): : 263 - 263
  • [6] Rare diseases and orphan drugs
    Taruscio, Domenica
    Capozzoli, Fiorentino
    Frank, Claudio
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2011, 47 (01): : 83 - 93
  • [7] Rare diseases and "orphan" drugs
    Hillcoat, BL
    MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (02) : 69 - 70
  • [8] Development of orphan drugs for rare diseases
    Yoo, Han-Wook
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2024, 67 (07) : 315 - 327
  • [9] Orphan drugs and rare diseases in Andorra
    Gea, E.
    Gil, E.
    Barral, N.
    Gonzalez, V.
    Soler, A.
    Avellanet, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 963 - 963
  • [10] The portal for rare diseases and orphan drugs
    Singh, Jatinder
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (02) : 168 - 169
12345